Abstract:Salah H Elsafi, 1 Saleh H Almutairi, 2 Mujahid A Alsulaimani, 3 Salma AlBahrani, 4 Thekra N Al-Maqati, 1 Wafa K Alanazi, 2 Mohammed N Alanazi, 2 Abdullah A Alamri, 2 Majed Hamoud Alkhathami, 5 Rakkad A Alshammari, 5 Naif F Alharbi, 5 Yaser A Al Naam 1 1 Clinical Laboratory Sciences. Prince Sultan Military College of Health Sciences, Dhahran, Saudia Arabia; 2 Pharmacy Services Department, King Fahad Military Medical Complex, Dhahran, Saudi Arabia; 3 Basic Medical Unit, Prince Sultan Military College of Health Sciences, Dhahran, Saudia Arabia; 4 Infectious Disease Unit, Specialty Internal Medicine, King Fahhd Military Medical Complex, Dhahran Saudi Arabia; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudia Arabia; 5 Department of Support Services, Prince Sultan Military College of Health Sciences, Dhahran, Saudia Arabia Correspondence: Yaser A Al Naam, Prince Sultan Military College of Health Sciences, P. O Box 33048, Dammam, 31448, Saudia Arabia, Email Background: Earlier reports suggested high rates of antibiotic utilization among COVID-19 patients despite the lack of direct evidence of their activity against viral pathogens. Different trends in antibiotic consumption during 2020 compared to 2019 have been reported. Purpose: The objective of this study is to assess the impact of COVID-19 pandemic on antibiotic consumption in the presence of active Antibiotic Stewardship Program. Methods: This study represented a five years assessment of the consumption of the commonly prescribed antibiotics measured as DDDs/100-Bed Days. We analyzed the data by using nonparametric Friedman and Friedman tests to compare the antibiotic consumption before and during the three subsequent waves of COVID-19. Results: Antibiotic consumption through the DDDs/100-BD has shown reduction in the median of antibiotics consumption of most antibiotics during the period of COVID-19 as compared to the pre-COVID-19 period, which was significant for meropenem and ciprofloxacin, except colomycin that slightly increased. Significant reduction in the consumption of imipenem and meropenem during the second and third waves as compared to the pre-COVID period. Throughout the years, significant reductions were observed between 2018 and 2019 (p=< .001), 2018 and 2020 (p=0.008), and 2018 and 2022 (p=0.002). Conclusion: The reduction in antibiotic consumption is attributed to the strong influence if the ASP and the reluctance of people to visit hospitals during the COVID-19 pandemic. Other related COVID-19 precautions such as physical distance, good hand hygiene, facemasks, that resulted in the prevention of secondary bacterial infections have contributed to the reduction in antibiotic utilization during the pandemic. Keywords: antimicrobial stewardship, ASP, COVID-19, defined daily doses, DDD, antibiotic consumption, Saudi Arabia Earlier reports suggested high rates of antibiotic utilization among COVID-19 patients despite the lack of direct evidence of their activity against viral pathogens. 1–3 A meta-analysis study showed a significant elevation of antibiotic prescribed for COVID-19 patients beyond the estimated prevalence of co-bacterial infections. 4 Bacterial co-infections among COVID-19 patients have been undoubtedly reported at low rates. 5 Therefore, the utilization of antibiotics in routine COVID-19 management has not been recommended. 6 However, patients with COVID-19 may develop secondary nosocomial infections with bacteria and fungi because of critical illness and prolonged hospitalizations. There is high concern that antimicrobials might be overused. This is because COVID-19 patients may receive both empiric and pathogen-directed broad-spectrum antimicrobials. Notwithstanding, it has been reported that more than half of the COVID-19 patients received antibiotics, while 72% of these did not have laboratory evidence of bacterial infection. 5 In fact, the prevalence of bacterial co-infection with COVID-19 was low. 7–11 Different trends in antibiotic consumption during 2020 compared to 2019 have been reported. 12 At the beginning of the pandemic, there was an increase in the prescribed antimicrobial due to early reports indicating that secondary bacterial infection resulted in great mortality. 13 It has been demonstrated that covid-19 pandemic associated with an increase in antimicrobial consumption. 14–16 Subsequently, a higher antimicrobial resistance rate among COVID-19 patients has been detected during the first 18 months of the pandemic. 17</s -Abstract Truncated-

Studies of radio-active phosphorus uptake in the diagnosis of intraocular and cutaneous melanomata.

Antimicrobial stewardship in the UK during the COVID-19 pandemic: a population-based cohort study and interrupted time-series analysis

Two new neuroprotective phenolic compounds from Gastrodia elata

Impact of COVID-19 on antibiotic usage in primary care: a retrospective analysis

The pattern of antibiotic utilisation among intensive care unit patients hospitalised in a Gauteng (South African) provincial tertiary hospital: Comparing findings before and during COVID-19

Impact of COVID-19 pandemic on the utilization and quality of antibiotic use in the primary care setting in England, March 2019-March 2023: a segmented interrupted time series analysis of over 53 million individuals

Impact of the COVID-19 Pandemic on Community Antibiotic Prescribing and Stewardship: A Qualitative Interview Study with General Practitioners in England

Analysis of the use of antibiotics by AWaRe categories during the COVID-19 pandemic in hospitals across Scotland: a national population-based study

Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the Coronavirus Disease 2019 Outbreak: An Interrupted Time Series Analysis of 2016–2021 Data

Understanding the impact of COVID-19 on antibiotic use in Canadian primary care: a matched-cohort study using EMR data

Ambulatory antibiotic prescription rates for acute respiratory infection rebound two years after the start of the COVID-19 pandemic

Antimicrobial Prescribing Patterns in GP Practices in Northern Ireland

Robust torque control of an elastic robotic arm based on invertibility and feedback stabilization

[Echographic markers of fetal chromosomopathies. Diagnostic possibilities with transvaginal ultrasonography and our experience].

The Effect of COVID-19 Vaccination on Outpatient Antibiotic Prescribing in Older Adults: A Self-Controlled Risk-Interval Study

Antimicrobial use in COVID-19 patients in the first phase of the SARS-CoV-2 pandemic: Rapid review and evidence synthesis

The impact of the COVID-19 pandemic on antibiotic consumption and prevalence of pathogens in primary and secondary healthcare settings in Northern Ireland

Incidence and treatment of group A streptococcal infections during covid-19 pandemic and 2022 outbreak: retrospective cohort study in England using OpenSAFELY-TPP

The state of current research on COVID-19 and antibiotic use: global implications for antimicrobial resistance

The Impact of the COVID-19 Pandemic on Pattern of Antibiotic and Opioid Prescriptions by Dentists in Alberta, Canada

The Trend of Antibiotic Consumption After the COVID-19 Pandemic: Approach to Future Outbreaks